 Christopher Lowry
Concepts (653)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin | 60 | 2022 | 298 | 10.960 |
Why?
| | Raphe Nuclei | 41 | 2019 | 110 | 10.030 |
Why?
| | Tryptophan Hydroxylase | 34 | 2022 | 52 | 6.650 |
Why?
| | Anxiety | 45 | 2023 | 857 | 5.120 |
Why?
| | Serotonergic Neurons | 16 | 2022 | 24 | 4.950 |
Why?
| | Mycobacterium | 12 | 2023 | 103 | 4.900 |
Why?
| | Stress, Psychological | 35 | 2021 | 960 | 4.840 |
Why?
| | Mycobacteriaceae | 11 | 2023 | 21 | 4.520 |
Why?
| | Dorsal Raphe Nucleus | 14 | 2023 | 27 | 3.800 |
Why?
| | Neurons | 43 | 2022 | 1311 | 3.710 |
Why?
| | Proto-Oncogene Proteins c-fos | 23 | 2019 | 184 | 3.640 |
Why?
| | Amygdala | 21 | 2022 | 172 | 3.640 |
Why?
| | Fear | 16 | 2023 | 299 | 3.600 |
Why?
| | Corticotropin-Releasing Hormone | 18 | 2018 | 76 | 3.590 |
Why?
| | Rats | 79 | 2022 | 5172 | 3.300 |
Why?
| | Behavior, Animal | 25 | 2023 | 476 | 3.220 |
Why?
| | Corticosterone | 24 | 2021 | 250 | 3.110 |
Why?
| | Gastrointestinal Microbiome | 15 | 2023 | 534 | 3.030 |
Why?
| | Microbiota | 15 | 2023 | 662 | 3.000 |
Why?
| | Animals | 165 | 2023 | 32741 | 2.640 |
Why?
| | Stress Disorders, Post-Traumatic | 14 | 2023 | 753 | 2.430 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 33 | 2.360 |
Why?
| | Rats, Wistar | 34 | 2020 | 392 | 2.280 |
Why?
| | Hyperthermia, Induced | 6 | 2023 | 67 | 2.170 |
Why?
| | Anti-Inflammatory Agents | 9 | 2023 | 456 | 2.170 |
Why?
| | Inflammation | 26 | 2023 | 2515 | 2.090 |
Why?
| | Antidepressive Agents | 9 | 2023 | 196 | 2.070 |
Why?
| | Extinction, Psychological | 4 | 2023 | 80 | 2.050 |
Why?
| | Depressive Disorder, Major | 9 | 2023 | 304 | 2.010 |
Why?
| | Central Nervous System | 10 | 2022 | 241 | 1.890 |
Why?
| | Pituitary-Adrenal System | 11 | 2019 | 158 | 1.890 |
Why?
| | Hypothalamo-Hypophyseal System | 12 | 2019 | 194 | 1.860 |
Why?
| | Mental Health | 6 | 2023 | 565 | 1.840 |
Why?
| | Anxiety Disorders | 11 | 2021 | 307 | 1.820 |
Why?
| | Brain | 27 | 2022 | 2381 | 1.760 |
Why?
| | Rats, Sprague-Dawley | 31 | 2022 | 2321 | 1.720 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 11 | 2022 | 72 | 1.710 |
Why?
| | Panic Disorder | 7 | 2017 | 21 | 1.630 |
Why?
| | Organic Cation Transport Proteins | 9 | 2021 | 28 | 1.560 |
Why?
| | Male | 126 | 2024 | 56694 | 1.460 |
Why?
| | Motor Activity | 12 | 2021 | 644 | 1.430 |
Why?
| | Microglia | 6 | 2023 | 207 | 1.410 |
Why?
| | Glucocorticoids | 6 | 2023 | 544 | 1.350 |
Why?
| | Bacterial Vaccines | 4 | 2018 | 60 | 1.340 |
Why?
| | Fluoxetine | 6 | 2023 | 46 | 1.310 |
Why?
| | Lipopolysaccharides | 6 | 2023 | 825 | 1.290 |
Why?
| | Citalopram | 2 | 2018 | 27 | 1.240 |
Why?
| | Social Isolation | 3 | 2013 | 54 | 1.230 |
Why?
| | Analysis of Variance | 23 | 2018 | 1239 | 1.230 |
Why?
| | Hypothalamus | 6 | 2019 | 152 | 1.230 |
Why?
| | Urocortins | 10 | 2019 | 19 | 1.200 |
Why?
| | Depressive Disorder | 3 | 2018 | 336 | 1.190 |
Why?
| | Carbolines | 9 | 2015 | 29 | 1.190 |
Why?
| | Probiotics | 2 | 2018 | 48 | 1.190 |
Why?
| | Body Temperature Regulation | 7 | 2019 | 70 | 1.170 |
Why?
| | Environment, Controlled | 3 | 2016 | 19 | 1.170 |
Why?
| | Vaccines, Inactivated | 3 | 2018 | 68 | 1.170 |
Why?
| | Neural Pathways | 12 | 2020 | 261 | 1.150 |
Why?
| | Tryptophan | 8 | 2022 | 138 | 1.140 |
Why?
| | Salamandridae | 11 | 2009 | 26 | 1.130 |
Why?
| | Mood Disorders | 3 | 2013 | 120 | 1.100 |
Why?
| | Disease Models, Animal | 20 | 2023 | 3648 | 1.100 |
Why?
| | Depression | 10 | 2023 | 1137 | 1.090 |
Why?
| | Immunomodulation | 3 | 2016 | 89 | 1.080 |
Why?
| | Dysbiosis | 2 | 2018 | 149 | 1.080 |
Why?
| | Immunohistochemistry | 20 | 2019 | 1657 | 1.040 |
Why?
| | Cell Count | 14 | 2015 | 308 | 1.040 |
Why?
| | Serotonin Receptor Agonists | 5 | 2017 | 27 | 1.030 |
Why?
| | Anti-Anxiety Agents | 5 | 2023 | 44 | 1.030 |
Why?
| | Hippocampus | 8 | 2022 | 710 | 1.010 |
Why?
| | RNA, Messenger | 9 | 2020 | 2632 | 0.980 |
Why?
| | Panic | 4 | 2017 | 11 | 0.980 |
Why?
| | Stress, Physiological | 11 | 2014 | 409 | 0.940 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 5 | 0.930 |
Why?
| | Arousal | 6 | 2023 | 153 | 0.910 |
Why?
| | Receptor, Serotonin, 5-HT1A | 8 | 2019 | 39 | 0.880 |
Why?
| | Veterans | 7 | 2024 | 1232 | 0.880 |
Why?
| | Septal Nuclei | 3 | 2019 | 17 | 0.880 |
Why?
| | Maternal Deprivation | 4 | 2019 | 14 | 0.870 |
Why?
| | Brain Injuries, Traumatic | 4 | 2020 | 301 | 0.870 |
Why?
| | Mental Disorders | 8 | 2022 | 899 | 0.860 |
Why?
| | Caffeine | 5 | 2018 | 61 | 0.850 |
Why?
| | Inflammation Mediators | 3 | 2018 | 486 | 0.850 |
Why?
| | Reflex, Startle | 4 | 2019 | 58 | 0.850 |
Why?
| | Social Behavior | 7 | 2022 | 273 | 0.830 |
Why?
| | Neurons, Afferent | 4 | 2012 | 89 | 0.830 |
Why?
| | Carbon Dioxide | 4 | 2010 | 212 | 0.820 |
Why?
| | RNA, Ribosomal, 16S | 10 | 2022 | 504 | 0.820 |
Why?
| | Prefrontal Cortex | 3 | 2018 | 264 | 0.810 |
Why?
| | Hot Temperature | 3 | 2022 | 326 | 0.810 |
Why?
| | Immunization | 9 | 2022 | 409 | 0.800 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 182 | 0.790 |
Why?
| | Feces | 5 | 2023 | 386 | 0.790 |
Why?
| | Hydroxyindoleacetic Acid | 11 | 2018 | 19 | 0.790 |
Why?
| | Veterans Health | 2 | 2024 | 165 | 0.780 |
Why?
| | Colitis | 4 | 2019 | 219 | 0.750 |
Why?
| | Exploratory Behavior | 5 | 2021 | 87 | 0.720 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 9 | 0.710 |
Why?
| | Mice, Inbred BALB C | 12 | 2023 | 1183 | 0.710 |
Why?
| | Mice | 32 | 2023 | 15311 | 0.710 |
Why?
| | Environment Design | 2 | 2016 | 22 | 0.690 |
Why?
| | Emotions | 5 | 2023 | 487 | 0.690 |
Why?
| | Toxoplasmosis | 4 | 2024 | 31 | 0.690 |
Why?
| | Humans | 83 | 2024 | 117083 | 0.680 |
Why?
| | Body Temperature | 4 | 2018 | 211 | 0.670 |
Why?
| | Locomotion | 6 | 2021 | 82 | 0.670 |
Why?
| | Synaptic Transmission | 4 | 2018 | 235 | 0.670 |
Why?
| | Serotonin Agents | 4 | 2015 | 8 | 0.660 |
Why?
| | Interleukin-4 | 1 | 2020 | 216 | 0.660 |
Why?
| | Dominance-Subordination | 2 | 2011 | 16 | 0.650 |
Why?
| | Genes, fos | 2 | 2010 | 36 | 0.620 |
Why?
| | Physical Conditioning, Animal | 2 | 2019 | 202 | 0.620 |
Why?
| | Catecholamines | 3 | 2005 | 99 | 0.610 |
Why?
| | Housing, Animal | 2 | 2016 | 46 | 0.610 |
Why?
| | Blood Proteins | 1 | 2020 | 235 | 0.610 |
Why?
| | Behavior | 1 | 2018 | 92 | 0.600 |
Why?
| | Swimming | 3 | 2021 | 45 | 0.600 |
Why?
| | Gene Expression Regulation | 9 | 2018 | 2408 | 0.590 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 9 | 0.590 |
Why?
| | Hypothermia | 1 | 2017 | 37 | 0.590 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 173 | 0.590 |
Why?
| | Circadian Rhythm | 4 | 2021 | 392 | 0.580 |
Why?
| | Vaccination | 3 | 2020 | 1215 | 0.580 |
Why?
| | Hypercapnia | 4 | 2012 | 50 | 0.570 |
Why?
| | Military Personnel | 3 | 2019 | 533 | 0.570 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 805 | 0.570 |
Why?
| | Psychological Trauma | 1 | 2017 | 52 | 0.570 |
Why?
| | Lipid Metabolism | 1 | 2020 | 467 | 0.560 |
Why?
| | Social Determinants of Health | 1 | 2018 | 136 | 0.560 |
Why?
| | Toxoplasma | 3 | 2024 | 35 | 0.560 |
Why?
| | Parvalbumins | 2 | 2020 | 19 | 0.550 |
Why?
| | Immune System | 2 | 2014 | 178 | 0.540 |
Why?
| | Brain Concussion | 2 | 2020 | 469 | 0.540 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 4 | 0.510 |
Why?
| | Vasotocin | 4 | 2000 | 5 | 0.500 |
Why?
| | Gene Expression | 7 | 2020 | 1466 | 0.480 |
Why?
| | Post-Concussion Syndrome | 1 | 2017 | 155 | 0.480 |
Why?
| | Hormone Replacement Therapy | 1 | 2015 | 80 | 0.470 |
Why?
| | Conditioning, Classical | 5 | 2020 | 88 | 0.470 |
Why?
| | Cytokines | 7 | 2023 | 1852 | 0.460 |
Why?
| | Proteomics | 1 | 2020 | 844 | 0.460 |
Why?
| | Immobility Response, Tonic | 1 | 2013 | 4 | 0.460 |
Why?
| | Intestines | 2 | 2014 | 326 | 0.450 |
Why?
| | Interleukin-6 | 4 | 2023 | 673 | 0.450 |
Why?
| | Sex Characteristics | 2 | 2013 | 648 | 0.450 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 541 | 0.440 |
Why?
| | Public Health | 2 | 2022 | 443 | 0.440 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2016 | 355 | 0.440 |
Why?
| | Mesencephalon | 2 | 2010 | 57 | 0.440 |
Why?
| | Pons | 2 | 2010 | 30 | 0.440 |
Why?
| | Cold Temperature | 1 | 2013 | 127 | 0.430 |
Why?
| | Life Style | 2 | 2014 | 432 | 0.430 |
Why?
| | GABA Antagonists | 6 | 2013 | 32 | 0.430 |
Why?
| | Mice, Inbred C57BL | 12 | 2022 | 4841 | 0.420 |
Why?
| | Time Factors | 12 | 2015 | 6240 | 0.410 |
Why?
| | GABAergic Neurons | 1 | 2012 | 22 | 0.410 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2017 | 152 | 0.410 |
Why?
| | Prosencephalon | 6 | 2018 | 48 | 0.410 |
Why?
| | Cushing Syndrome | 1 | 2011 | 10 | 0.400 |
Why?
| | Kynurenine | 5 | 2018 | 79 | 0.400 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2015 | 1889 | 0.390 |
Why?
| | Rats, Long-Evans | 6 | 2021 | 100 | 0.390 |
Why?
| | Porphyromonas gingivalis | 2 | 2022 | 17 | 0.380 |
Why?
| | Socioeconomic Factors | 2 | 2014 | 1106 | 0.380 |
Why?
| | Breast Neoplasms | 1 | 2022 | 1883 | 0.380 |
Why?
| | Suicide | 4 | 2020 | 500 | 0.380 |
Why?
| | Brain Mapping | 5 | 2007 | 516 | 0.380 |
Why?
| | Bronchi | 1 | 2012 | 241 | 0.380 |
Why?
| | Third Ventricle | 1 | 2010 | 14 | 0.360 |
Why?
| | Light | 3 | 2008 | 335 | 0.360 |
Why?
| | Female | 35 | 2024 | 60665 | 0.360 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 147 | 0.360 |
Why?
| | Suicide, Attempted | 3 | 2019 | 316 | 0.360 |
Why?
| | Animals, Newborn | 5 | 2018 | 797 | 0.350 |
Why?
| | Cognition | 4 | 2022 | 988 | 0.340 |
Why?
| | Interneurons | 1 | 2010 | 102 | 0.340 |
Why?
| | Fenfluramine | 1 | 2009 | 13 | 0.340 |
Why?
| | Prebiotics | 2 | 2021 | 23 | 0.340 |
Why?
| | Amish | 2 | 2019 | 8 | 0.320 |
Why?
| | TRPV Cation Channels | 1 | 2008 | 29 | 0.320 |
Why?
| | Pets | 2 | 2018 | 21 | 0.320 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2018 | 475 | 0.320 |
Why?
| | Brain Chemistry | 4 | 2007 | 116 | 0.320 |
Why?
| | Medulla Oblongata | 4 | 2012 | 33 | 0.310 |
Why?
| | Sexual Behavior, Animal | 4 | 2006 | 49 | 0.310 |
Why?
| | RNA, Bacterial | 2 | 2020 | 176 | 0.300 |
Why?
| | Schizophrenia | 3 | 2016 | 417 | 0.300 |
Why?
| | Sleep Deprivation | 2 | 2020 | 167 | 0.300 |
Why?
| | Age Factors | 7 | 2021 | 2951 | 0.300 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 15 | 0.300 |
Why?
| | Encephalitis | 2 | 2020 | 127 | 0.300 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2008 | 130 | 0.290 |
Why?
| | Relaxin | 2 | 2018 | 15 | 0.290 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.290 |
Why?
| | Neuropeptides | 3 | 2018 | 66 | 0.290 |
Why?
| | Allosteric Site | 1 | 2007 | 17 | 0.290 |
Why?
| | Limbic System | 1 | 2007 | 42 | 0.290 |
Why?
| | Rats, Inbred F344 | 4 | 2019 | 244 | 0.290 |
Why?
| | Vaccines | 1 | 2012 | 380 | 0.290 |
Why?
| | Maze Learning | 6 | 2021 | 86 | 0.280 |
Why?
| | Aging | 4 | 2022 | 1653 | 0.280 |
Why?
| | Histamine | 2 | 2006 | 65 | 0.270 |
Why?
| | Receptors, GABA-A | 1 | 2007 | 88 | 0.270 |
Why?
| | Restraint, Physical | 4 | 2015 | 91 | 0.270 |
Why?
| | Indomethacin | 1 | 2006 | 74 | 0.270 |
Why?
| | 5-Hydroxytryptophan | 5 | 2022 | 22 | 0.270 |
Why?
| | Benzodiazepines | 1 | 2007 | 116 | 0.270 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 72 | 0.270 |
Why?
| | Up-Regulation | 4 | 2012 | 837 | 0.270 |
Why?
| | Biguanides | 1 | 2005 | 12 | 0.270 |
Why?
| | Receptors, Serotonin, 5-HT3 | 1 | 2005 | 17 | 0.270 |
Why?
| | Telemetry | 2 | 2017 | 35 | 0.260 |
Why?
| | In Situ Hybridization | 5 | 2012 | 301 | 0.260 |
Why?
| | Prolactin | 2 | 2005 | 94 | 0.260 |
Why?
| | Hypothalamic Area, Lateral | 1 | 2005 | 3 | 0.260 |
Why?
| | Antibodies, Protozoan | 3 | 2024 | 29 | 0.260 |
Why?
| | Environmental Microbiology | 2 | 2019 | 41 | 0.260 |
Why?
| | Bacteria | 3 | 2020 | 754 | 0.250 |
Why?
| | Vimentin | 1 | 2005 | 60 | 0.250 |
Why?
| | Life Change Events | 1 | 2005 | 129 | 0.250 |
Why?
| | Adrenal Medulla | 1 | 2004 | 7 | 0.240 |
Why?
| | Dopamine | 3 | 2018 | 240 | 0.240 |
Why?
| | Macrophages | 2 | 2023 | 1297 | 0.240 |
Why?
| | Fibroblast Growth Factor 8 | 2 | 2014 | 27 | 0.240 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 10 | 0.240 |
Why?
| | Helicobacter Infections | 2 | 2021 | 24 | 0.230 |
Why?
| | Neuroimmunomodulation | 2 | 2019 | 69 | 0.230 |
Why?
| | Tuberculosis, Bovine | 1 | 2023 | 3 | 0.230 |
Why?
| | Cerebral Cortex | 1 | 2007 | 392 | 0.230 |
Why?
| | Mice, Inbred Strains | 2 | 2023 | 404 | 0.230 |
Why?
| | Diazepam | 1 | 2023 | 27 | 0.230 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2018 | 36 | 0.230 |
Why?
| | Suicidal Ideation | 2 | 2019 | 397 | 0.220 |
Why?
| | Immunoglobulin G | 4 | 2024 | 786 | 0.220 |
Why?
| | Adult | 18 | 2022 | 31009 | 0.210 |
Why?
| | Friends | 1 | 2023 | 48 | 0.210 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 205 | 0.210 |
Why?
| | Mucins | 1 | 2022 | 60 | 0.210 |
Why?
| | Receptors, Neuropeptide | 2 | 2012 | 11 | 0.210 |
Why?
| | Random Allocation | 4 | 2009 | 339 | 0.210 |
Why?
| | Coinfection | 1 | 2023 | 118 | 0.210 |
Why?
| | Planets | 1 | 2021 | 2 | 0.200 |
Why?
| | Hydrazines | 3 | 2018 | 28 | 0.200 |
Why?
| | Norepinephrine | 5 | 2005 | 205 | 0.200 |
Why?
| | Serotonin Antagonists | 2 | 2015 | 30 | 0.200 |
Why?
| | Neopterin | 2 | 2022 | 9 | 0.200 |
Why?
| | Helicobacter pylori | 1 | 2021 | 30 | 0.200 |
Why?
| | Populus | 1 | 2021 | 9 | 0.200 |
Why?
| | Piperazines | 3 | 2010 | 314 | 0.200 |
Why?
| | Hygiene | 2 | 2014 | 32 | 0.200 |
Why?
| | Frailty | 1 | 2024 | 119 | 0.190 |
Why?
| | Diet, High-Fat | 2 | 2022 | 247 | 0.190 |
Why?
| | Cholera Toxin | 3 | 2013 | 28 | 0.190 |
Why?
| | Adrenalectomy | 2 | 2015 | 80 | 0.190 |
Why?
| | Groundwater | 1 | 2021 | 33 | 0.190 |
Why?
| | Brain Stem | 3 | 2006 | 102 | 0.190 |
Why?
| | Carrier Proteins | 1 | 2005 | 719 | 0.190 |
Why?
| | Microdialysis | 5 | 2019 | 51 | 0.190 |
Why?
| | Escape Reaction | 2 | 2017 | 62 | 0.190 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 11 | 0.190 |
Why?
| | Multiple Trauma | 1 | 2021 | 79 | 0.180 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2012 | 187 | 0.180 |
Why?
| | Epinephrine | 2 | 2005 | 165 | 0.180 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1049 | 0.180 |
Why?
| | Mycobacterium tuberculosis | 1 | 2023 | 272 | 0.180 |
Why?
| | Bile Acids and Salts | 1 | 2021 | 177 | 0.180 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 30 | 0.180 |
Why?
| | Shock | 1 | 2021 | 76 | 0.180 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 9 | 0.180 |
Why?
| | United States | 6 | 2024 | 12385 | 0.180 |
Why?
| | Communicable Diseases | 1 | 2022 | 133 | 0.180 |
Why?
| | DNA, Bacterial | 2 | 2020 | 311 | 0.180 |
Why?
| | Neuropsychiatry | 1 | 2020 | 15 | 0.180 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 56 | 0.170 |
Why?
| | Autoradiography | 2 | 2009 | 72 | 0.170 |
Why?
| | Periodontitis | 1 | 2020 | 42 | 0.170 |
Why?
| | United States Department of Veterans Affairs | 2 | 2024 | 557 | 0.170 |
Why?
| | Individuality | 2 | 2019 | 147 | 0.170 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2019 | 5 | 0.170 |
Why?
| | Psycholinguistics | 1 | 2019 | 17 | 0.170 |
Why?
| | Middle Aged | 10 | 2020 | 27183 | 0.170 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 75 | 0.170 |
Why?
| | Phobic Disorders | 1 | 2019 | 26 | 0.170 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 39 | 0.170 |
Why?
| | Memory, Episodic | 1 | 2019 | 39 | 0.160 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 8 | 0.160 |
Why?
| | Mice, Knockout | 4 | 2019 | 2648 | 0.160 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 337 | 0.160 |
Why?
| | Hypothalamus, Middle | 2 | 2010 | 2 | 0.160 |
Why?
| | Autism Spectrum Disorder | 2 | 2020 | 325 | 0.160 |
Why?
| | Alarmins | 1 | 2018 | 25 | 0.160 |
Why?
| | Yohimbine | 2 | 2010 | 9 | 0.160 |
Why?
| | Adiponectin | 1 | 2020 | 221 | 0.160 |
Why?
| | Nervous System | 1 | 1998 | 63 | 0.160 |
Why?
| | Housing | 1 | 2019 | 116 | 0.160 |
Why?
| | Biomarkers | 3 | 2024 | 3550 | 0.150 |
Why?
| | Biogenic Monoamines | 2 | 2009 | 14 | 0.150 |
Why?
| | HMGB1 Protein | 1 | 2018 | 48 | 0.150 |
Why?
| | MicroRNAs | 2 | 2014 | 627 | 0.150 |
Why?
| | Nesting Behavior | 1 | 2018 | 17 | 0.150 |
Why?
| | Phenylalanine | 1 | 2018 | 61 | 0.150 |
Why?
| | Grooming | 2 | 2009 | 4 | 0.150 |
Why?
| | Vertebrates | 1 | 1998 | 59 | 0.150 |
Why?
| | Vasopressins | 1 | 1998 | 64 | 0.150 |
Why?
| | Injections, Intraventricular | 2 | 2009 | 72 | 0.150 |
Why?
| | Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.150 |
Why?
| | Amphibians | 1 | 1998 | 49 | 0.150 |
Why?
| | Food Chain | 1 | 2017 | 37 | 0.150 |
Why?
| | Desipramine | 2 | 2015 | 9 | 0.150 |
Why?
| | Receptors, Glucocorticoid | 2 | 2017 | 132 | 0.150 |
Why?
| | Noise | 1 | 2018 | 67 | 0.150 |
Why?
| | Genetic Fitness | 1 | 2018 | 55 | 0.150 |
Why?
| | Altitude | 1 | 2021 | 412 | 0.150 |
Why?
| | Tyrosine | 1 | 2018 | 220 | 0.150 |
Why?
| | Impulsive Behavior | 1 | 2018 | 106 | 0.150 |
Why?
| | Songbirds | 1 | 2018 | 39 | 0.150 |
Why?
| | Helicobacter | 1 | 2016 | 5 | 0.150 |
Why?
| | Hydrocortisone | 2 | 2018 | 269 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 741 | 0.140 |
Why?
| | Soil Microbiology | 1 | 2019 | 184 | 0.140 |
Why?
| | Psychomotor Performance | 1 | 2019 | 274 | 0.140 |
Why?
| | Gliadin | 1 | 2016 | 12 | 0.140 |
Why?
| | Lipids | 1 | 2020 | 584 | 0.140 |
Why?
| | Video Recording | 2 | 2009 | 151 | 0.140 |
Why?
| | Tissue Distribution | 3 | 2006 | 326 | 0.140 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 540 | 0.140 |
Why?
| | Drug Administration Routes | 2 | 2007 | 39 | 0.140 |
Why?
| | Affect | 1 | 2018 | 243 | 0.140 |
Why?
| | Immunity, Cellular | 1 | 2018 | 267 | 0.140 |
Why?
| | Down-Regulation | 1 | 2018 | 606 | 0.140 |
Why?
| | Biogenic Amines | 1 | 1996 | 4 | 0.140 |
Why?
| | Rectum | 1 | 2017 | 152 | 0.140 |
Why?
| | Species Specificity | 3 | 2023 | 561 | 0.140 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.140 |
Why?
| | Epilepsy | 1 | 2020 | 291 | 0.140 |
Why?
| | Adrenal Glands | 2 | 2016 | 73 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 4510 | 0.130 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1144 | 0.130 |
Why?
| | Urban Population | 1 | 2018 | 404 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 504 | 0.130 |
Why?
| | Radioimmunoassay | 2 | 2009 | 162 | 0.130 |
Why?
| | Membrane Potentials | 1 | 1996 | 253 | 0.130 |
Why?
| | Staining and Labeling | 2 | 2006 | 142 | 0.130 |
Why?
| | Learning | 1 | 2019 | 362 | 0.130 |
Why?
| | Sleep | 4 | 2021 | 654 | 0.120 |
Why?
| | Argonaute Proteins | 1 | 2014 | 28 | 0.120 |
Why?
| | Hypoxia | 1 | 2021 | 950 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2015 | 74 | 0.120 |
Why?
| | Receptors, Steroid | 1 | 1995 | 54 | 0.120 |
Why?
| | Rural Population | 1 | 2018 | 455 | 0.120 |
Why?
| | White Matter | 1 | 2016 | 109 | 0.120 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 173 | 0.120 |
Why?
| | Alzheimer Disease | 1 | 2020 | 457 | 0.120 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2014 | 53 | 0.120 |
Why?
| | Extracellular Space | 2 | 2019 | 123 | 0.120 |
Why?
| | Urbanization | 1 | 2014 | 26 | 0.120 |
Why?
| | Chronic Disease | 2 | 2019 | 1619 | 0.120 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 284 | 0.120 |
Why?
| | Oncogene Proteins v-fos | 1 | 2013 | 12 | 0.120 |
Why?
| | Proteins | 1 | 2020 | 930 | 0.110 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 52 | 0.110 |
Why?
| | Bradycardia | 2 | 2012 | 48 | 0.110 |
Why?
| | Emigration and Immigration | 1 | 2014 | 46 | 0.110 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2013 | 29 | 0.110 |
Why?
| | Comorbidity | 2 | 2017 | 1487 | 0.110 |
Why?
| | Respiration Disorders | 1 | 2014 | 66 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2018 | 4507 | 0.110 |
Why?
| | Receptors, Opioid | 2 | 1990 | 18 | 0.110 |
Why?
| | Skin | 3 | 2023 | 655 | 0.110 |
Why?
| | Biological Evolution | 2 | 2014 | 437 | 0.110 |
Why?
| | Receptors, Angiotensin | 1 | 2013 | 10 | 0.110 |
Why?
| | Weight Gain | 2 | 2019 | 481 | 0.110 |
Why?
| | Rodentia | 1 | 2013 | 43 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 798 | 0.110 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2013 | 13 | 0.110 |
Why?
| | Amphetamine | 1 | 2012 | 22 | 0.110 |
Why?
| | Body Weight | 1 | 2017 | 901 | 0.110 |
Why?
| | Pilot Projects | 1 | 2017 | 1396 | 0.110 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2011 | 151 | 0.110 |
Why?
| | Avoidance Learning | 1 | 2013 | 65 | 0.110 |
Why?
| | Resilience, Psychological | 1 | 2014 | 100 | 0.110 |
Why?
| | Young Adult | 5 | 2019 | 10680 | 0.110 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 3 | 0.110 |
Why?
| | Angiotensin II | 1 | 2013 | 107 | 0.110 |
Why?
| | Sodium Lactate | 2 | 2013 | 5 | 0.110 |
Why?
| | Brain Injuries | 1 | 2017 | 449 | 0.100 |
Why?
| | Weaning | 1 | 2012 | 55 | 0.100 |
Why?
| | Phenotype | 3 | 2021 | 2892 | 0.100 |
Why?
| | Memory | 3 | 2018 | 211 | 0.100 |
Why?
| | Cohort Studies | 2 | 2019 | 5051 | 0.100 |
Why?
| | Homeostasis | 1 | 2015 | 588 | 0.100 |
Why?
| | Quality of Life | 1 | 2022 | 2375 | 0.100 |
Why?
| | Hypertension | 2 | 2012 | 1179 | 0.100 |
Why?
| | Electroshock | 3 | 2017 | 139 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 131 | 0.090 |
Why?
| | Environmental Exposure | 1 | 2014 | 385 | 0.090 |
Why?
| | Signal Transduction | 2 | 2015 | 4606 | 0.090 |
Why?
| | Sanitation | 1 | 2010 | 52 | 0.090 |
Why?
| | Neuronal Tract-Tracers | 1 | 2010 | 2 | 0.090 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2010 | 19 | 0.090 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 157 | 0.090 |
Why?
| | Receptors, Adrenergic | 2 | 2006 | 35 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 197 | 0.090 |
Why?
| | Cell Lineage | 1 | 2012 | 314 | 0.090 |
Why?
| | Radiography | 1 | 2013 | 843 | 0.090 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 104 | 0.090 |
Why?
| | Diet | 3 | 2023 | 1128 | 0.090 |
Why?
| | Feeding Behavior | 2 | 2006 | 590 | 0.090 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 80 | 0.090 |
Why?
| | Social Dominance | 1 | 2009 | 17 | 0.090 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2007 | 68 | 0.090 |
Why?
| | Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 399 | 0.080 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 924 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 390 | 0.080 |
Why?
| | Thermosensing | 1 | 2008 | 10 | 0.080 |
Why?
| | Pyridines | 2 | 2013 | 421 | 0.080 |
Why?
| | Transfection | 1 | 2011 | 877 | 0.080 |
Why?
| | Temperature | 1 | 2011 | 602 | 0.080 |
Why?
| | Immune Tolerance | 1 | 2010 | 330 | 0.080 |
Why?
| | Pargyline | 1 | 2008 | 2 | 0.080 |
Why?
| | Biological Transport | 2 | 2006 | 378 | 0.080 |
Why?
| | Seroepidemiologic Studies | 2 | 2019 | 142 | 0.080 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 10 | 0.080 |
Why?
| | Mice, Transgenic | 4 | 2014 | 1993 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 386 | 0.080 |
Why?
| | Central Nervous System Stimulants | 2 | 2012 | 139 | 0.080 |
Why?
| | Somatoform Disorders | 1 | 2007 | 37 | 0.080 |
Why?
| | Acoustic Stimulation | 1 | 2009 | 309 | 0.070 |
Why?
| | Synapses | 1 | 2010 | 340 | 0.070 |
Why?
| | Seasons | 2 | 2020 | 463 | 0.070 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2007 | 8 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2008 | 299 | 0.070 |
Why?
| | Aged | 3 | 2024 | 19367 | 0.070 |
Why?
| | Amino Acid Sequence | 1 | 2011 | 2032 | 0.070 |
Why?
| | Tryptamines | 1 | 2006 | 4 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 129 | 0.070 |
Why?
| | Darkness | 1 | 2006 | 22 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 682 | 0.070 |
Why?
| | Tegmentum Mesencephali | 1 | 2006 | 4 | 0.070 |
Why?
| | Tissue Fixation | 1 | 2005 | 28 | 0.070 |
Why?
| | Chromatography, Liquid | 2 | 2021 | 350 | 0.070 |
Why?
| | Blood-Brain Barrier | 1 | 2006 | 106 | 0.070 |
Why?
| | Cell Membrane | 2 | 2022 | 681 | 0.070 |
Why?
| | Drug Interactions | 1 | 2007 | 346 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2008 | 683 | 0.060 |
Why?
| | Median Eminence | 1 | 2005 | 4 | 0.060 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2005 | 13 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 696 | 0.060 |
Why?
| | Blood Pressure | 2 | 2013 | 1618 | 0.060 |
Why?
| | Stilbamidines | 1 | 2005 | 10 | 0.060 |
Why?
| | Injections | 1 | 2005 | 161 | 0.060 |
Why?
| | Heart Atria | 1 | 2005 | 110 | 0.060 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 30 | 0.060 |
Why?
| | Perfusion | 1 | 2005 | 150 | 0.060 |
Why?
| | Autoimmunity | 1 | 2010 | 829 | 0.060 |
Why?
| | Microinjections | 2 | 2015 | 78 | 0.060 |
Why?
| | Neurons, Efferent | 1 | 2004 | 7 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 16 | 0.060 |
Why?
| | Nerve Fibers | 1 | 2005 | 88 | 0.060 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 170 | 0.060 |
Why?
| | Pregnancy | 4 | 2022 | 5653 | 0.060 |
Why?
| | Genotype | 2 | 2020 | 1854 | 0.060 |
Why?
| | Action Potentials | 2 | 2011 | 418 | 0.060 |
Why?
| | Prednisone | 1 | 2024 | 233 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 87 | 0.050 |
Why?
| | Blood Glucose | 2 | 2011 | 1931 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2016 | 485 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 249 | 0.050 |
Why?
| | Carbidopa | 1 | 2022 | 4 | 0.050 |
Why?
| | Orexin Receptors | 2 | 2012 | 4 | 0.050 |
Why?
| | Psychoneuroimmunology | 1 | 2022 | 12 | 0.050 |
Why?
| | Exercise | 1 | 2012 | 1629 | 0.050 |
Why?
| | Receptors, Interleukin-6 | 1 | 2022 | 35 | 0.050 |
Why?
| | Polysomnography | 2 | 2019 | 154 | 0.050 |
Why?
| | Fathers | 1 | 2022 | 47 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 1172 | 0.050 |
Why?
| | Models, Biological | 2 | 2007 | 1689 | 0.050 |
Why?
| | Bacteroidetes | 1 | 2021 | 22 | 0.050 |
Why?
| | Endophenotypes | 1 | 2021 | 14 | 0.050 |
Why?
| | Social Justice | 1 | 2022 | 66 | 0.050 |
Why?
| | Anhedonia | 1 | 2021 | 9 | 0.050 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 11 | 0.050 |
Why?
| | Pregnancy Trimester, First | 1 | 2022 | 128 | 0.050 |
Why?
| | Granulocytes | 1 | 2021 | 77 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2021 | 80 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2022 | 129 | 0.050 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 207 | 0.050 |
Why?
| | Rivers | 1 | 2021 | 55 | 0.050 |
Why?
| | Trees | 1 | 2021 | 65 | 0.050 |
Why?
| | Dreams | 1 | 2000 | 11 | 0.050 |
Why?
| | Dietary Sucrose | 1 | 2021 | 55 | 0.050 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 228 | 0.050 |
Why?
| | Microelectrodes | 1 | 2000 | 33 | 0.050 |
Why?
| | Cations | 1 | 2021 | 79 | 0.050 |
Why?
| | Choice Behavior | 1 | 2022 | 160 | 0.050 |
Why?
| | Policy | 1 | 2022 | 138 | 0.050 |
Why?
| | Cattle | 1 | 2023 | 957 | 0.050 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 211 | 0.050 |
Why?
| | Benzomorphans | 2 | 1990 | 2 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 2000 | 69 | 0.050 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 293 | 0.050 |
Why?
| | Cathelicidins | 1 | 2020 | 39 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 78 | 0.040 |
Why?
| | Metagenomics | 1 | 2021 | 135 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2000 | 80 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 460 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 78 | 0.040 |
Why?
| | Normetanephrine | 1 | 2019 | 2 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 520 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2020 | 498 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 340 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 367 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2020 | 200 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2019 | 71 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 78 | 0.040 |
Why?
| | Interpersonal Relations | 2 | 2015 | 341 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 2156 | 0.040 |
Why?
| | Reaction Time | 1 | 2000 | 375 | 0.040 |
Why?
| | Social Environment | 2 | 2010 | 287 | 0.040 |
Why?
| | Axons | 1 | 2000 | 182 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 418 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2024 | 474 | 0.040 |
Why?
| | Optogenetics | 1 | 2020 | 96 | 0.040 |
Why?
| | Metabolome | 1 | 2021 | 287 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 130 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 325 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 161 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 51 | 0.040 |
Why?
| | Extracellular Fluid | 2 | 2010 | 32 | 0.040 |
Why?
| | Germany | 1 | 2018 | 89 | 0.040 |
Why?
| | Agoraphobia | 1 | 2017 | 6 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 250 | 0.040 |
Why?
| | Feathers | 1 | 2018 | 35 | 0.040 |
Why?
| | Nucleic Acid Probes | 1 | 1997 | 1 | 0.040 |
Why?
| | Ethylmaleimide | 1 | 1997 | 18 | 0.040 |
Why?
| | Thionucleotides | 1 | 1997 | 34 | 0.040 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2017 | 32 | 0.040 |
Why?
| | Dogs | 1 | 2018 | 356 | 0.040 |
Why?
| | Risk Factors | 2 | 2024 | 8874 | 0.040 |
Why?
| | Biodiversity | 1 | 2021 | 371 | 0.040 |
Why?
| | Body Size | 1 | 2018 | 93 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2018 | 187 | 0.040 |
Why?
| | Nerve Net | 1 | 2020 | 226 | 0.040 |
Why?
| | Picrotoxin | 1 | 2017 | 13 | 0.040 |
Why?
| | Oxytocin | 1 | 1997 | 45 | 0.040 |
Why?
| | Quinolines | 2 | 2010 | 128 | 0.040 |
Why?
| | Computational Biology | 1 | 2020 | 540 | 0.030 |
Why?
| | Arizona | 1 | 2016 | 68 | 0.030 |
Why?
| | Anisotropy | 1 | 2016 | 63 | 0.030 |
Why?
| | Attention | 1 | 2019 | 390 | 0.030 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2015 | 3 | 0.030 |
Why?
| | Self Report | 1 | 2020 | 696 | 0.030 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 13 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 67 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 459 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 658 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 298 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 5 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 372 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 762 | 0.030 |
Why?
| | Environment | 1 | 2017 | 342 | 0.030 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2014 | 23 | 0.030 |
Why?
| | Mifepristone | 1 | 2014 | 65 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 775 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 111 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1125 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2016 | 217 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 291 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4124 | 0.030 |
Why?
| | Electrochemical Techniques | 1 | 2014 | 39 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2014 | 34 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2015 | 113 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 281 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 494 | 0.030 |
Why?
| | Memory Disorders | 1 | 2014 | 154 | 0.030 |
Why?
| | Mothers | 1 | 1999 | 682 | 0.030 |
Why?
| | Receptors, Opioid, kappa | 2 | 1990 | 11 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 256 | 0.030 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 8 | 0.030 |
Why?
| | Cues | 1 | 2015 | 295 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1355 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2009 | 502 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 32 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1314 | 0.030 |
Why?
| | Odds Ratio | 1 | 2015 | 981 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2038 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1758 | 0.030 |
Why?
| | Naloxone | 2 | 1990 | 96 | 0.030 |
Why?
| | Orexins | 1 | 2012 | 5 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2481 | 0.030 |
Why?
| | Naphthyridines | 1 | 2012 | 16 | 0.030 |
Why?
| | Androgens | 1 | 1994 | 167 | 0.030 |
Why?
| | Benzoxazoles | 1 | 2012 | 16 | 0.030 |
Why?
| | Imidazoles | 1 | 2013 | 214 | 0.030 |
Why?
| | Urea | 1 | 2012 | 76 | 0.030 |
Why?
| | Fetal Development | 1 | 2014 | 251 | 0.020 |
Why?
| | Respiration | 1 | 2012 | 182 | 0.020 |
Why?
| | Muscle Strength | 1 | 2014 | 279 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 331 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2831 | 0.020 |
Why?
| | Estrogens | 1 | 1994 | 326 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 61 | 0.020 |
Why?
| | Morphinans | 1 | 1989 | 7 | 0.020 |
Why?
| | Receptors, Opioid, mu | 1 | 1990 | 52 | 0.020 |
Why?
| | Heart Rate | 1 | 2013 | 708 | 0.020 |
Why?
| | Mass Screening | 1 | 2016 | 1035 | 0.020 |
Why?
| | Organic Chemicals | 1 | 2010 | 129 | 0.020 |
Why?
| | Morphine | 1 | 1990 | 125 | 0.020 |
Why?
| | Allylglycine | 1 | 2007 | 2 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 24 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2007 | 30 | 0.020 |
Why?
| | Child | 2 | 2019 | 18881 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 260 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 159 | 0.020 |
Why?
| | Pain | 1 | 2013 | 719 | 0.020 |
Why?
| | Pyrroles | 1 | 2008 | 186 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 65 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 3956 | 0.020 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 150 | 0.020 |
Why?
| | Obesity | 1 | 2019 | 2661 | 0.020 |
Why?
| | Cimetidine | 1 | 1986 | 16 | 0.020 |
Why?
| | Ranitidine | 1 | 1986 | 13 | 0.020 |
Why?
| | Growth Hormone | 1 | 1986 | 107 | 0.020 |
Why?
| | Pyrimidines | 1 | 2008 | 379 | 0.020 |
Why?
| | Testis | 1 | 1986 | 143 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 392 | 0.020 |
Why?
| | Inspiratory Capacity | 1 | 2004 | 2 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2004 | 259 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3420 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2227 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 9263 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 751 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 57 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 12843 | 0.010 |
Why?
| | Pyramidal Cells | 1 | 1999 | 51 | 0.010 |
Why?
| | Atrophy | 1 | 1999 | 157 | 0.010 |
Why?
| | Progesterone | 1 | 1999 | 239 | 0.010 |
Why?
| | RNA, Complementary | 1 | 1997 | 3 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 215 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1997 | 17 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1997 | 13 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1997 | 53 | 0.010 |
Why?
| | Estradiol | 1 | 1999 | 465 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 2070 | 0.010 |
Why?
| | Testosterone | 1 | 1994 | 346 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 4663 | 0.010 |
Why?
| | Dyspepsia | 1 | 1986 | 9 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1986 | 124 | 0.000 |
Why?
| | Glucose Tolerance Test | 1 | 1986 | 362 | 0.000 |
Why?
| | Insulin | 1 | 1986 | 2135 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|